1. Editorial: Sudden Death in Heart Failure: An Ounce of Prediction is Worth a Pound of Prevention 
Ragavendra R. Baliga, MD, MBA 
Heart Failure Clinics 
Volume 7, Issue 2, Pages xiii-xviii (April 2011)
DOI: /j.hfc
Copyright © 2011 Elsevier Inc. Terms and Conditions

2. Fig. 1
Severity of heart failure and mode of death. CHF, congestive heart failure.
(From Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353(9169):2001–7; with permission.)
Heart Failure Clinics 2011 7, xiii-xviiiDOI: ( /j.hfc )
Copyright © 2011 Elsevier Inc. Terms and Conditions

3. Fig. 2
Antiarrhythmic therapy can perform worse than placebo. Inferior performance of antiarrhythmic therapy compared with control group in the SCD-HeFT NYHA functional class III patients (top) and the MUSTT (bottom). CI, confidence interval; EPG, electrophysiology-guided.
(From Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52(14):1111–21; with permission.)
Heart Failure Clinics 2011 7, xiii-xviiiDOI: ( /j.hfc )
Copyright © 2011 Elsevier Inc. Terms and Conditions

4. Fig. 3
Appropriate shocks outnumber control arrhythmic mortality in 6 of 7 trials. AMIOVIRT, Amiodarone versus Implantable Cardioverter Defibrillator Trial; AVID, Antiarrhythmics versus Implantable Defibrillators trial; DEFINITE, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial; DINAMIT, Defibrillators in Acute Myocardial Infarction Trial.
(Adapted from Germano JJ, Reynolds M, Essebag V, et al. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006;97(8):1255–61; with permission; and Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52(14):1111–21; with permission.)
Heart Failure Clinics 2011 7, xiii-xviiiDOI: ( /j.hfc )
Copyright © 2011 Elsevier Inc. Terms and Conditions

5. Ragavendra R. Baliga, MD, MBA, Consulting Editor
Heart Failure Clinics 2011 7, xiii-xviiiDOI: ( /j.hfc )
Copyright © 2011 Elsevier Inc. Terms and Conditions

6. James B. Young, MD, Consulting Editor
Heart Failure Clinics 2011 7, xiii-xviiiDOI: ( /j.hfc )
Copyright © 2011 Elsevier Inc. Terms and Conditions